Recursion Pharmaceuticals
Builds investigational medicines through automated biology, AI chemistry, and partner programs.
$3.35
After-hours close+0.02 (+0.60%)
At close$3.33(−3.20%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.23 | — | — |
| Aug 2026 | −$0.24 | −$0.25 | −4.2% |
| May 2026 | −$0.30 | −$0.22 | +26.7% |
| Feb 2026 | −$0.28 | −$0.21 | +25.0% |
| Nov 2025 | −$0.38 | −$0.36 | +5.3% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Apr 2021 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | −$0.23 | — | — | $14.2M | — | — |
| Aug 5, 2026 | −$0.24 | −$0.25 | −4.2% | $11.0M | $7.3M | −33.4% |
| May 6, 2026 | −$0.30 | −$0.22 | +26.7% | $15.8M | $6.3M | −60.1% |
| Feb 25, 2026 | −$0.28 | −$0.21 | +25.0% | $24.5M | $35.4M | +44.0% |
| Nov 5, 2025 | −$0.38 | −$0.36 | +5.3% | $24.6M | $5.2M | −78.9% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | ||||||
| Aug 5, 2025 | ||||||
| May 5, 2025 | ||||||
| Feb 28, 2025 | ||||||
| Nov 6, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 9, 2024 | ||||||
| Feb 27, 2024 | ||||||
| Nov 9, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 8, 2023 | ||||||
| Feb 27, 2023 | ||||||
| Nov 8, 2022 | ||||||
| Aug 9, 2022 | ||||||
| May 10, 2022 | ||||||
| Mar 23, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Aug 13, 2021 | ||||||
| May 12, 2021 | ||||||
| Apr 16, 2021 | ||||||
| Sep 30, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||